Skip to main content

Table 1 Summary of mouse experiments

From: Pre-treatment with IL2 gene therapy alleviates Staphylococcus aureus arthritis in mice

Experiment

Controls

Treatment regimen

S. aureus strain

Bacterial dose (CFU/mouse)

Mice

Infected mice

Healthy mice

No treatment

LS-1

1 × 107

NMRI

N = 44, one experiment

rAAV-IL2

rAAV-LUC

1010 vg at day −19 prior to bacterial inoculation

LS-1

5 × 107

C57BL/6

N = 60, two experiments

Adoptive transfer

PBS

0.9 × 106 CD4+CD25+ cells at day −2 prior to bacterial inoculation

LS-1

5 × 107

C57BL/6

N = 12, one experiment

IL2 treatment

PBS

Daily injections, starting at day 3 post bacterial inoculation

LS-1

5 × 107

C57BL/6

N = 18, two experiments

Anti-CD25 antibody treatment

Rat IgG1 antibody

One injection at day −3 prior bacterial inoculation and at day 3 post bacterial inoculation

(1) LS-1

(2) Newman

(1) 3.5 × 107

(2) 6.5 × 106

(1) C57BL/6

N = 20, one experiment

(2) NMRI

N = 28, one experiment